XML 72 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment Information
9 Months Ended
Sep. 30, 2015
Segment Information  
Segment Information

13.Segment Information

 

Our reporting segments consist of Medical Equipment Solutions (“MES”), Clinical Engineering Solutions (“CES”) and Surgical Services (“SS”). Certain operating information for our segments as well as a reconciliation of total Company gross margin to loss before income taxes and noncontrolling interest was as follows:

 

Medical Equipment Solutions

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

    

2015

    

2014

    

2015

    

2014

Revenues

 

$

68,985

 

$

67,861

 

$

214,154

 

$

216,771

Cost of revenue

 

 

30,134

 

 

32,204

 

 

92,466

 

 

97,919

Medical equipment depreciation

 

 

15,043

 

 

16,340

 

 

45,712

 

 

51,843

Gross margin

 

$

23,808

 

$

19,317

 

$

75,976

 

$

67,009

 

Clinical Engineering Solutions

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

    

2015

    

2014

    

2015

    

2014

Revenues

 

$

25,401

 

$

23,717

 

$

74,581

 

$

68,505

Cost of revenue

 

 

20,063

 

 

18,670

 

 

59,333

 

 

54,454

Gross margin

 

$

5,338

 

$

5,047

 

$

15,248

 

$

14,051

 

Surgical Services

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

    

2015

    

2014

    

2015

    

2014

Revenues

 

$

16,727

 

$

14,887

 

$

48,154

 

$

43,890

Cost of revenue

 

 

8,780

 

 

7,982

 

 

25,681

 

 

24,418

Medical equipment depreciation

 

 

1,547

 

 

1,426

 

 

4,513

 

 

4,153

Gross margin

 

$

6,400

 

$

5,479

 

$

17,960

 

$

15,319

 

Total Gross Margin and Reconciliation to Loss Before Income Taxes and Noncontrolling Interest

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

    

2015

    

2014

    

2015

    

2014

Total gross margin

 

$

35,546

 

$

29,843

 

$

109,184

 

$

96,379

Selling, general and administrative

 

 

30,633

 

 

26,539

 

 

91,825

 

 

85,416

(Gain) on settlement

 

 

 —

 

 

 —

 

 

(5,718)

 

 

 —

Restructuring, acquisition and integration expenses

 

 

 —

 

 

 —

 

 

 —

 

 

1,820

Intangible asset impairment charge

 

 

 —

 

 

 —

 

 

 —

 

 

34,900

Interest expense

 

 

13,250

 

 

13,264

 

 

39,810

 

 

39,922

Loss before income taxes and noncontrolling interest

 

$

(8,337)

 

$

(9,960)

 

$

(16,733)

 

$

(65,679)

 

Total Assets by Reporting Segment

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

    

September 30,

    

December 31,

 

 

 

2015

 

2014

 

Medical Equipment Solutions

 

$

597,426

 

$

624,444

 

Clinical Engineering Solutions

 

 

109,940

 

 

110,562

 

Surgical Services

 

 

100,531

 

 

98,906

 

Total Company Assets

 

$

807,897

 

$

833,912

 

 

The following table provides additional detail on percentage of revenue for each group of similar products sold or services provided in the MES, CES and SS segments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2015

 

2014

 

    

2015

 

2014

 

MES

 

 

 

 

 

 

 

 

 

 

Equipment usage solutions

 

59.4

%  

59.8

%  

 

60.6

%  

61.1

%  

Equipment/disposable sales

 

2.7

 

3.9

 

 

3.0

 

4.8

 

 

 

62.1

 

63.7

 

 

63.6

 

65.9

 

CES

 

 

 

 

 

 

 

 

 

 

Service solutions

 

22.9

 

22.3

 

 

22.1

 

20.8

 

SS

 

 

 

 

 

 

 

 

 

 

Equipment usage solutions

 

14.7

 

13.8

 

 

14.1

 

13.1

 

Equipment/disposable sales

 

0.3

 

0.2

 

 

0.2

 

0.2

 

 

 

15.0

 

14.0

 

 

14.3

 

13.3

 

Total revenues

 

100.0

%  

100.0

%  

 

100.0

%  

100.0

%